Ledger.Open graph →
SEC Form D · filed August 10, 2010

Pathway Therapeutics, Inc

Offering
$11.4M
Sold
$8.8M
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (2)

Julie Cherrington · San Francisco, CAExec · DirectorRyan D. Cahill · Evanston, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗